BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $157.1 million in its first quarter.

The Bridgewater, New Jersey-based company said it had a loss of $1.06 per share.

The results exceeded Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.22 per share.

The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $75.5 million in the period, which did not meet Street forecasts. Five analysts surveyed by Zacks expected $78.9 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSM at https://www.zacks.com/ap/INSM